EndoChoice Holdings Inc. (GI) Reaches New 12-Month Low at $3.64
EndoChoice Holdings Inc. (NYSE:GI)’s share price reached a new 52-week low on Friday . The stock traded as low as $3.64 and last traded at $3.67, with a volume of 65,952 shares. The stock had previously closed at $3.82.
GI has been the subject of several recent research reports. William Blair downgraded EndoChoice Holdings from an “outperform” rating to a “market perform” rating in a research report on Thursday, August 4th. JPMorgan Chase & Co. downgraded EndoChoice Holdings from an “overweight” rating to a “neutral” rating in a research report on Thursday, August 4th. Zacks Investment Research raised EndoChoice Holdings from a “sell” rating to a “hold” rating in a research report on Tuesday, May 10th. Finally, Stifel Nicolaus dropped their price target on EndoChoice Holdings from $10.00 to $7.00 and set a “buy” rating for the company in a research report on Thursday, August 4th. One research analyst has rated the stock with a sell rating, three have given a hold rating and one has issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $7.42.
The firm’s market capitalization is $98.46 million. The company’s 50 day moving average price is $4.55 and its 200 day moving average price is $4.71.
EndoChoice Holdings (NYSE:GI) last released its earnings results on Wednesday, August 3rd. The company reported ($0.99) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.52) by $0.47. The business earned $19.30 million during the quarter, compared to analysts’ expectations of $20.67 million. During the same period last year, the business earned ($1.01) EPS. EndoChoice Holdings’s revenue for the quarter was up 3.8% compared to the same quarter last year. On average, analysts expect that EndoChoice Holdings Inc. will post ($2.53) EPS for the current year.
Endochoice Holdings, Inc, formerly ECPM Holdings, LLC, is a medical device company. The Company is focused on designing and commercializing a platform of products for gastrointestinal (GI) caregivers. It offers a range of products and services that span single-use devices and infection control products, pathology and imaging systems.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.